- Home
- GPCR vs DAVA Comparison
GPCR vs DAVA Comparison
Compare GPCR & DAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- DAVA
- Stock Information
- Founded
- GPCR 2016
- DAVA 2000
- Country
- GPCR United States
- DAVA United Kingdom
- Employees
- GPCR N/A
- DAVA N/A
- Industry
- GPCR
- DAVA EDP Services
- Sector
- GPCR
- DAVA Technology
- Exchange
- GPCR Nasdaq
- DAVA Nasdaq
- Market Cap
- GPCR 1.8B
- DAVA 1.5B
- IPO Year
- GPCR 2023
- DAVA 2018
- Fundamental
- Price
- GPCR $34.17
- DAVA $26.88
- Analyst Decision
- GPCR Buy
- DAVA Buy
- Analyst Count
- GPCR 5
- DAVA 11
- Target Price
- GPCR $86.80
- DAVA $41.10
- AVG Volume (30 Days)
- GPCR 677.5K
- DAVA 560.8K
- Earning Date
- GPCR 11-13-2024
- DAVA 11-12-2024
- Dividend Yield
- GPCR N/A
- DAVA N/A
- EPS Growth
- GPCR N/A
- DAVA N/A
- EPS
- GPCR N/A
- DAVA 0.16
- Revenue
- GPCR N/A
- DAVA $1,001,724,970.00
- Revenue This Year
- GPCR N/A
- DAVA $10.55
- Revenue Next Year
- GPCR N/A
- DAVA $10.35
- P/E Ratio
- GPCR N/A
- DAVA $167.84
- Revenue Growth
- GPCR N/A
- DAVA N/A
- 52 Week Low
- GPCR $26.61
- DAVA $23.28
- 52 Week High
- GPCR $66.38
- DAVA $81.06
- Technical
- Relative Strength Index (RSI)
- GPCR 35.81
- DAVA 52.55
- Support Level
- GPCR $33.85
- DAVA $23.40
- Resistance Level
- GPCR $38.48
- DAVA $33.42
- Average True Range (ATR)
- GPCR 2.62
- DAVA 1.47
- MACD
- GPCR -0.36
- DAVA 0.46
- Stochastic Oscillator
- GPCR 3.67
- DAVA 34.73
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.